Initial Experience with a New Transurethral Microwave Thermotherapy Treatment Protocol &amp;lsquo;30&amp;ndash;Minute TUMT&amp;rsquo;

Pace, Giuseppe; Selvaggio, Oscar; Palumbo, Fabrizio; Selvaggi, Francesco Paolo

doi:10.1159/000052477

Cited by 4 publications

(6 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…After 3 months of follow-up, a mean Q max value of 17.2 ml/s was reported, compared to a mean 10.4 ml/s before treatment. The Q max increase after '30-min TUMT', compared to older Prostasoft 2.5 software, is similar to that obtained after TURP mostly after 6-12 months, as preliminary results in the literature seem to confirm [27]. Ninety-five percent of treated subjects demonstrated cavitation inside the prostatic adenoma.…”

Section: Discussionsupporting

confidence: 77%

High-Energy Microwave Thermotherapy in the Treatment of Benign Prostatic Hyperplasia

Cavarretta

Scremin

Cucciarrè³

et al. 2003

Urol Int

View full text Add to dashboard Cite

Introduction: Transurethral microwave thermotherapy is an anesthesia-free, outpatient method of treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). Our results with the use of this technique in 25 patients are reported. Materials and Methods: Twenty-five patients with BPH, 8 of whom with complete urinary retention, were treated with high-energy transurethral microwave thermotherapy (HE-TUMT) (Prostatron system). Preoperative investigations included digital rectal examination, urinary free flow rate, PSA, urinalysis, urine culture, transrectal ultrasonography, urodynamic evaluation, International Prostatic Symptom Score (IPSS) and quality of life (QoL). Main selection criteria included: large prostate, high surgical risk, reluctance to undergo surgery. All patients were obstructed according to the Abrams-Griffith’s nomogram. For the statistical analysis a repeated-measures, one-way ANOVA was performed on previously non-catheterized patients. Results: Six of the 8 patients with catheter before treatment were able to urinate spontaneously with no significant post-voiding residual urine. In the 17 remaining patients, IPSS decreased from a mean of 18.5 at baseline to 7.30 and QoL from a mean of 3.9 to 1.2. Mean maximum flow rates during uroflowmetry increased from 8.5 to 16.9 ml/s. P_det Q_max decreased from a mean of 83.0 cm H₂O at baseline to 50.7 cm H₂O and Q_max increased from a mean of 6.8 ml/s at baseline to 15.1 ml/s during the pressure-flow study. After TUMT, 13 patients were unobstructed and 4 equivocal according to the Abrams-Griffith’s nomogram. Conclusion: Our study performed in a selected population of patients with BPH documents the efficiency and safety of HE-TUMT. This technique appears to be a valid therapeutic option, particularly in patients with high surgical risk.

show abstract

Section: Discussionsupporting

confidence: 77%

High-Energy Microwave Thermotherapy in the Treatment of Benign Prostatic Hyperplasia

Cavarretta

Scremin

Cucciarrè³

et al. 2003

Urol Int

View full text Add to dashboard Cite

show abstract

“…Tolerability of this new high-energy protocol is high, in our opinion, and it is better than the old protocol, 2.5, because of the shorter treatment time [8,9].…”

Section: Discussionmentioning

confidence: 77%

“…The system for TUMT consists of a microwave generator, a urethral treatment catheter with a microwave antenna and a fiberoptic temperature monitoring system (accuracy B 0.1°C) inside the catheter and in a rectal probe [8,9]. Computer software with 30 min duration and a maximum microwave energy of 80 W controls the microwave generator and the cooling system in response to preset temperatures of the rectal and urethral thermosensors.…”

Section: Methodsmentioning

confidence: 99%

“…However, the number of TURPs for BPH has decreased by 43% in the period 1987-1994 within the US Medicare Program (253,000 TURPs in 1987 vs. 145,000 in 1994). There are several explanations, one being the increased number of new minimally invasive procedures available today [2][3][4][5][6][7][8][9].…”

Section: Introductionmentioning

confidence: 99%

“…Low-and high-energy transurethral microwave thermotherapy (LE-and HE-TUMT) are minimally invasive single session treatments that can be reliably performed with out-patient management and without severe adverse events [6,8,9].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

30-Minutes-Tumt

Dicuio¹,

Knutson²,

Veselý³

et al. 2004

Urol Int

View full text Add to dashboard Cite

Introduction: Primary objective: to investigate if 30-MINUTES-TUMT can be performed under topical anesthesia and analgesics. Secondary objectives: to evaluate retrospectively analgesics and to study parameters connected with pain. Materials and Methods: Eighty-nine patients underwent TUMT. Patients were divided into four groups with different medications. Paracetamol and tolterodin-L-tartrate were administered in all groups. The first group was also given hydromorphone hydrochloride and atropine sulphate, the second group dextropropoxyphene, the third group morphine and diclofenac, and the fourth group morphine and dextropropoxyphene. Pain during TUMT was registered using the VAS scale. Results: Pain during TUMT was (VAS in mm), respectively, total-first-second-third-fourth group: at 5 min –30, 31, 12, 28, 35; at 15 min –30, 23, 16, 25, 34; at 25 min –30, 28, 18, 25, 35. All patients accepted the treatment. No significant difference between the different drug schedules was noticed. Conclusions: It is possible to treat patients with 30-MINUTES-TUMT with local anesthesia and analgesics. The pain can be accepted by all patients.

show abstract